Bard Financial Services Inc. Sells 15,700 Shares of CVS Health Co. (NYSE:CVS)

Bard Financial Services Inc. cut its holdings in CVS Health Co. (NYSE:CVS) by 10.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 141,857 shares of the pharmacy operator’s stock after selling 15,700 shares during the quarter. Bard Financial Services Inc.’s holdings in CVS Health were worth $6,368,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. New York Life Investment Management LLC increased its holdings in CVS Health by 0.3% in the 2nd quarter. New York Life Investment Management LLC now owns 172,501 shares of the pharmacy operator’s stock worth $10,188,000 after purchasing an additional 493 shares in the last quarter. Savant Capital LLC boosted its position in CVS Health by 20.2% during the 2nd quarter. Savant Capital LLC now owns 64,362 shares of the pharmacy operator’s stock worth $3,801,000 after buying an additional 10,796 shares during the period. Norden Group LLC grew its holdings in CVS Health by 68.3% during the 2nd quarter. Norden Group LLC now owns 11,493 shares of the pharmacy operator’s stock worth $679,000 after acquiring an additional 4,663 shares during the last quarter. Chris Bulman Inc acquired a new position in CVS Health in the 2nd quarter valued at approximately $46,000. Finally, W Advisors LLC acquired a new position in shares of CVS Health during the second quarter worth $450,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 1.1 %

NYSE CVS traded up $0.51 during trading hours on Monday, hitting $46.28. The company’s stock had a trading volume of 10,417,791 shares, compared to its average volume of 10,927,900. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company’s 50-day simple moving average is $52.84 and its two-hundred day simple moving average is $57.08. The company has a market capitalization of $58.24 billion, a PE ratio of 11.75, a price-to-earnings-growth ratio of 0.85 and a beta of 0.54. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $83.25.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.21 earnings per share. Research analysts anticipate that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.75%. CVS Health’s payout ratio is currently 67.51%.

Analyst Ratings Changes

Several brokerages have commented on CVS. Royal Bank of Canada cut their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Piper Sandler cut their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Finally, Truist Financial dropped their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.